In SSc, B cells exhibit a higher tendency to produce vasculogenic mediators such as vascular endothelial growth factor and angiopoietin-1 compared to healthy controls, with no difference observed between patients with and without PAH (67). Here, VEGFA is linked to pulmonary arterial hypertension.